|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
11.230 +0.140 (+1.262%) | 2025/12 - Final USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | 325,522 | 75,647 | (286,911) | (120,292) | (136,790) |
| Net Cash from / (used in) Investing Activities | (171,951) | (1,456,363) | (357,728) | (443,296) | (212,548) |
| Net Cash from / (used in) Financing Activities | (144,889) | 66,519 | 1,068,260 | 419,317 | 902,141 |
| Increase / (Decrease) in Cash & Cash Equivalents | 8,682 | (1,314,197) | 423,621 | (144,271) | 552,803 |
| Cash & Cash Equivalents at beginning of period | 131,990 | 1,446,403 | 1,023,999 | 1,180,971 | 629,058 |
| Effect of Foreign Exchange Rate Changes | 1,816 | (216) | (1,217) | (12,701) | (890) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 142,488 | 131,990 | 1,446,403 | 1,023,999 | 1,180,971 |
| Remarks: | Real time quote last updated: 16/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -532,830 |
| %Change | -- |
| EPS / (LPS) | USD -0.246 |
| NBV Per Share ($) | USD 1.811 |